253 related articles for article (PubMed ID: 19301612)
1. [Histopathologic changes due to combination of androgen deprivation and transurethral microwave thermotherapy in patients with localized prostate cancer].
Suzuki R; Jujo Y; Koshiba K; Hoshiai O; Endo T; Aihara M; Nakajo H; Ohori M
Hinyokika Kiyo; 2009 Feb; 55(2):79-85. PubMed ID: 19301612
[TBL] [Abstract][Full Text] [Related]
2. [Histopathological changes due to transurethural microwave thermotherapy associated with androgen deprivation therapy in patients with localized prostate cancer].
Jujo Y; Koshiba K; Suzuki R; Hoshiai O; Endo T; Aihara M; Katsuta M; Nakajo H
Nihon Hinyokika Gakkai Zasshi; 2006 Mar; 97(3):575-82. PubMed ID: 16613159
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression in untreated and androgen-deprived patients with prostate cancer.
Aslan G; Cimen S; Yorukoglu K; Tuna B; Sonmez D; Mungan U; Celebi I
Pathol Res Pract; 2005; 201(8-9):593-8. PubMed ID: 16259113
[TBL] [Abstract][Full Text] [Related]
5. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer.
Hennenfent BR
Br J Urol; 1998 Jul; 82(1):166. PubMed ID: 9698691
[No Abstract] [Full Text] [Related]
6. Changes in chromatin phenotype predict the response to hormonal deprivation therapy in patients with prostate cancer.
Mohamed M; Greif PA; Diamond J; Sharafeldin O; Maxwell P; Montironi R; O'Brien A; Young M; Hamilton PW
BJU Int; 2009 Feb; 103(3):391-8. PubMed ID: 19021609
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. Delayed diagnosis of prostate cancer with neuroendocrine differentiation after laser TURP.
Meeks JJ; Habermacher GM; Le B; Smith ND
Urology; 2008 Oct; 72(4):948.e11-2. PubMed ID: 18342929
[TBL] [Abstract][Full Text] [Related]
9. Anemia in patients on combined androgen block therapy for prostate cancer.
Qian LX; Hua LX; Wu HF; Sui YG; Cheng SG; Zhang W; Li J; Wang XR
Asian J Androl; 2004 Dec; 6(4):383-4. PubMed ID: 15546035
[TBL] [Abstract][Full Text] [Related]
10. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
[TBL] [Abstract][Full Text] [Related]
11. Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
Foote JE; Crawford ED
Semin Urol; 1988 Nov; 6(4):291-302. PubMed ID: 3068767
[No Abstract] [Full Text] [Related]
12. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
[TBL] [Abstract][Full Text] [Related]
13. Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy.
Patel R; Faiena I; Geltzeiler J
Can J Urol; 2015 Apr; 22(2):7752-4. PubMed ID: 25891342
[TBL] [Abstract][Full Text] [Related]
14. Prostate specific antigen half-time and prostate specific antigen doubling time as predictors of response to androgen deprivation therapy for metastatic prostate cancer.
Park YH; Hwang IS; Jeong CW; Kim HH; Lee SE; Kwak C
J Urol; 2009 Jun; 181(6):2520-4; discussion 2525. PubMed ID: 19371894
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling of transurethral resection samples provides insight into molecular mechanisms of hormone refractory prostate cancer.
Stoss O; Werther M; Zielinski D; Middel P; Jost N; Rüschoff J; Henkel T; Albers P
Prostate Cancer Prostatic Dis; 2008; 11(2):166-72. PubMed ID: 17646850
[TBL] [Abstract][Full Text] [Related]
16. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
[TBL] [Abstract][Full Text] [Related]
17. [Study of sexual hormone changes in prostate cancer patients before and after androgen deprivation therapy].
Ying J; Yao DH; Ren XM
Zhonghua Nan Ke Xue; 2003 Jun; 9(3):191-2, 196. PubMed ID: 12861832
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on prostatic cancer patients].
Yasumoto R; Asakawa M
Hinyokika Kiyo; 1989 Jan; 35(1):65-9. PubMed ID: 2729021
[TBL] [Abstract][Full Text] [Related]
19. [Stage A prostate cancer: comparison of subclassification between Japanese rule and TNM, and outcome].
Tanaka M; Suzuki N; Nakatsu H; Murakami S; Matsuzaki O; Shimazaki J
Hinyokika Kiyo; 2003 Oct; 49(10):579-82. PubMed ID: 14655599
[TBL] [Abstract][Full Text] [Related]
20. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
